Local view for "http://purl.org/linkedpolitics/eu/plenary/2006-06-13-Speech-2-343"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2006-06-13"^^xsd:date2
dcterms:Is Part Of	lp_eu:European Monitoring Centre for Drugs and Drug Addiction (debate)2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20060613.31.2-343"2
lpv:hasSubsequent	lp_eu:2006-06-13-Speech-2-3442
lpv:speaker	lp:Carlos Coelho2
lpv:spokenAs	substitute; ITRE (2004-07-22--2007-01-14)3 unknown; Coligaçao Força Portugal (PPD/PSD.CDS-PP) (2004-07-20--2007-11-22)3 chair; Temporary Committee on the alleged use of European countries by the CIA for the transport and illegal detention of prisoners (2006-01-26--2007-02-14)3 member; LIBE (2004-07-21--2007-01-14)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2004-10-13--2009-07-13)3 member_of_the_bureau; EPP-ED (2004-11-14--2009-07-13)3
lpv:translated text	"The problem of drug use, in particular cocaine, is on the increase, and the number of young people experimenting with drugs in Europe is also growing. This clearly demonstrates that much remains to be done in the fight against drugs. The European Monitoring Centre for Drugs and Drug Addiction has played an important role in compiling and publishing information on drugs and their use and has encouraged organisations in the Member States to communicate and exchange best practices. As Mr Pirker has pointed out, however, there need to be common criteria and standard data-collection methods, since that is the only way of ensuring that data relating to drug issues are objective, reliable and above all comparable. A solution needs to be found quickly to the problem of data being unavailable or hardly comparable in some Member States, which hampers general monitoring of the European drugs situation. I should like to commend Mrs Brepoels on this report and on the excellent outcome that she has achieved. We are adopting this proposed review of the regulation at the end of three years of negotiation, which primarily involves amending the originally agreed legal basis, putting Parliament in the position of co-legislator. I should like to express my satisfaction at the more prominent role given to the Monitoring Centre, which will take account of emerging trends in poly-drug use, including the combined use of licit and illicit psychoactive substances, and the move to adapt the operation of the Centre's bodies in order to take account of enlargement. Lastly, I should like to draw attention to the global nature of drug use, which means that we have to place European analysis in a broader context. It is also important to step up cooperation with non-EU countries, especially as many of the drugs that enter the EU do so from non-EU countries."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph